A clinical-stage biotechnology company
Focused on developing innovative anti-inflammatory
therapies for the treatment of cardiovascular disease
fast facts
- name Cardiol Theraputics Inc.
- symbol CRDL
- exchange TSX
- financials View Filings
- shares outstanding 36,590,594 as of 04/14/2021
- industry Technology & Medical
- transfer agent Computershare Investor Services Inc.
- website https://www.cardiolrx.com
recent updates
-
-
Corporate Update -
Cardiol Therapeutics Announces Pricing of Public Offering of Units -
-
-
most recent messages
top rated messages